Use of Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease at Expert Scleroderma Centers in the United States

By sjmartinez • April 11, 2025

Luo Y, Assassi S, Mayes MD, Frech TM, Steen VD, Richardson C, Chung L, Sandorfi N, VanBuren JM, Harding M, Alvey JS, Skaug B, McMahan Z, Lakin KS, Zahn C, Bracken SJ, Lebiedz-Odrobina DJ, Molitor JA, Evnin LB, Moore DF, Shah A, Castelino FV, Volkmann ER, Hant FN, Makol A, Shah AA, Hummers LK, Gordon JK, Khanna D, Bernstein EJ. Use of Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease at Expert Scleroderma Centers in the United States. Ann Am Thorac Soc. 2025 Apr 10. doi: 10.1513/AnnalsATS.202410-1045RL. Epub ahead of print. PMID: 40208257.

Tags: Publications, Rheumatology

The Effect of Urban Heat Island Intensity on the Rate of Emergency Department Visits for Acute Myocardial Infarctions

Lilley B, Amubieya O, Ziaeian B. The Effect of Urban Heat Island Intensity on the Rate of Emergency Department Visits for Acute Myocardial Infarctions. Eur[...]

Impact of e-cigarettes and flavoured vapes on respiratory health: where are we now?

Omcikus M, Tashkin DP, Dimic-Janjic S, Barjaktarevic I. Impact of e-cigarettes and flavoured vapes on respiratory health: where are we now? Curr Opin Pulm Med.[...]

KEYLYNK-009: Pembrolizumab Plus Olaparib in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer and Clinical Benefit From First-Line Pembrolizumab Plus Chemotherapy

Rugo HS, Cescon DW, Robson ME, Im SA, Dalenc F, Yañez Ruiz E, Reyes-Cosmelli F, Walshe JM, Im YH, Kulyk S, Dudnichenko O, Llinás-Quintero N,[...]